12.55
+0.79(+6.72%)
Currency In USD
Address
27 Drydock Avenue
Boston, MA 02210
United States of America
Phone
877 422 5362
Sector
Healthcare
Industry
Biotechnology
Employees
834
First IPO Date
April 19, 2021
| Name | Title | Pay | Year Born |
| Dr. Jason Kelly Ph.D. | Founder, Chief Executive Officer & Director | 250,000 | 1981 |
| Dr. Reshma P. Shetty | Founder, President, Chief Operating Officer & Director | 250,000 | 1981 |
| Mr. Mark E. Dmytruk | Chief Financial Officer | 460,000 | 1972 |
| Mr. Austin Che Ph.D. | Founder, Head of Strategy & Treasurer | 0 | N/A |
| Mr. Daniel Marshall | Senior Manager of Communications & Ownership | 0 | N/A |
| Mr. Bartholomew Canton Ph.D. | Founder, Chief Technology Officer & Secretary | 0 | N/A |
| Ms. Karen Tepichin | General Counsel & Secretary | 0 | N/A |
| Mr. Steven P. Coen CPA | Chief Accounting Officer | 0 | N/A |
| Ms. Samantha Sutton | Head of People | 0 | N/A |
| Mr. Thomas Knight Jr. | Founder | 0 | N/A |
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.